28-day Repeat Dose and Drug Interaction Study With Orvepitant (GW823296)

Clinical trial NCT00511654 · COMPLETED

Trial details

NCT number: NCT00511654
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder

Start date: 2007-06-12
Primary completion: 2008-01-11
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.